Log In
Print
BCIQ
Print
Print this Print this
 

teplizumab (MGA031)

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionHumanized mAb against CD3
Molecular Target CD3
Mechanism of ActionBinds CD3; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsIslet transplant; Treat recent-onset Type I diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today